Prolonged blood concentration of prednisolone after intravenous injection of liposomal palmitoyl prednisolone

Journal of Controlled Release

Volumn 112, Issue 3, 2006, Pages 320-328

  Teshima, Mugen ^a   Fumoto, Shintaro ^b   Nishida, Koyo ^b   Nakamura, Junzo ^b   Ohyama, Kaname ^a   Nakamura, Tadahiro ^a   Ichikawa, Nobuhiro ^a   Nakashima, Mikiro ^a   Sasaki, Hitoshi ^a  

^a NAGASAKI UNIVERSITY HOSPITAL   (Japan)

^b NAGASAKI UNIVERSITY   (Japan)

Author keywords

Drug delivery system; Lipophilic derivative; Liposomes; Polyethylene glycol; Prednisolone

Indexed keywords

BLOOD; CONTROLLED DRUG DELIVERY; LIPIDS; PHARMACOKINETICS; POLYETHYLENE GLYCOLS;

DRUG DELIVERY SYSTEM; LIPOPHILIC DERIVATIVE; LIPOSOMES; PREDNISOLONE;

DRUG PRODUCTS;

CHOLESTEROL; DRUG BINDING PROTEIN; LEVO ALPHA DISTEAROYLPHOSPHATIDYLETHANOLAMINE; LIPOSOME; MACROGOL 2000; MACROGOL 400; PALMITOYL PREDNISOLONE; PHOSPHATIDYLCHOLINE; PREDNISOLONE; PREDNISOLONE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; DRUG BINDING; DRUG BLOOD LEVEL; DRUG TISSUE LEVEL; LIPOPHILICITY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; INJECTIONS, INTRAVENOUS; LIPOSOMES; MALE; ORGAN SPECIFICITY; PREDNISOLONE; RATS; RATS, WISTAR;

EID: 33646689376     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jconrel.2006.03.004     Document Type: Article

References (28)

1. Robert Jr. C.H., and Ferid M. In: Molinoff P.B., and Ruddon R.W. (Eds). Goodman and Gilman's The Pharmacological Basis of Therapeutics (1996), The McGraw-Hill Companies, Inc. Press, New York 1459-1489
2. Metselaar J.M., Wauben M.H., Wagenaar-Hilbers J.P., Boerman O.C., and Storm G. Complete remission of experimental arthritis by joint targeting of glucocorticoids with long-circulating liposomes. Arthritis Rheum. 48 (2003) 2059-2066
3. Schmidt J., Metselaar J.M., Wauben M.H., Toyka K.V., Storm G., and Gold R. Drug targeting by long-circulating liposomal glucocorticosteroids increases therapeutic efficacy in a model of multiple sclerosis. Brain 126 (2003) 1895-1904
4. Liao J., Hayashi K., Horikoshi S., Ushijima H., Kimura J., and Tomino Y. Effect of steroid-liposome on immunohistopathology of IgA nephropathy in ddY mice. Nephron 89 (2001) 194-200
5. Mizushima Y., Hamano T., and Yokoyama K. Tissue distribution and anti-inflammatory activity of corticosteroids incorporated in lipid emulsion. Ann. Rheum. Dis. 41 (1982) 263-267
6. Hoshi K., Mizushima Y., Shiokawa Y., Kageyama T., Honma M., Kashiwazaki S., Shichikawa K., Tsunematsu T., and Kaneko K. Double-blind study with liposteroid in rheumatoid arthritis. Drugs Exp. Clin. Res. 11 (1985) 621-626
7. Teshima M., Kawakami S., Nishida K., Nakamura J., Sakaeda T., Terazono H., Kitahara T., Nakashima M., and Sasaki H. Prednisolone retention in integrated liposomes by chemical approach and pharmaceutical approach. J. Control. Release 97 (2004) 211-218
8. Huang C. Studies on phosphatidylcholine vesicles. Formation and physical characteristics. Biochemistry 8 (1969) 344-352
9. Cannell G.R., Mortimer R.H., Maguire D.J., and Addison R.S. Liquid chromatographic analysis of prednisolone, prednisone and their 20-reduced metabolites in perfusion media. J. Chromatogr. 563 (1991) 341-347
10. Yamaoka K., Tanigawara Y., Nakagawa T., and Uno T. A pharmacokinetic analysis program (MULTI) for microcomputer. J. Pharmacobio-Dyn. 4 (1981) 879-885
11. Munck A., Mendel D.B., Smith L.I., and Orti E. Glucocorticoid receptors and actions. Am. Rev. Respir. Dis. 141 (1990) S2-S10
12. Downie W.W. Steroid therapy. Scott. Med. J. 21 (1976) 188-193
13. Sawada K., Akizawa Y., Ono N., and Miyake H. Anti-inflammatory activity of prednisolone farnesylate (PNF-21) gel, a new transdermal corticosteroid. Jpn. Pharmacol. Ther. 20 (1992) 4075-4079 (Japanese)
14. Rocci Jr. M.L., Johnson N.F., and Jusko W.J. Serum protein binding of prednisolone in four species. J. Pharm. Sci. 69 (1980) 977-978
15. Boudinot F.D., and Jusko W.J. Fluid shifts and other factors affecting plasma protein binding of prednisolone by equilibrium dialysis. J. Pharm. Sci. 73 (1984) 774-780
16. 14C prednisolone. J. Endocrinol. 18 (1959) 278-291
17. Garg V., and Jusko W.J. Simultaneous analysis of prednisone, prednisolone and their major hydroxylated metabolites in urine by high-performance liquid chromatography. J. Chromatogr. 567 (1991) 39-47
18. Burczynski F.J., and Cai Z.S. Palmitate uptake by hepatocyte suspensions: effect of albumin. Am. J. Physiol. 267 (1994) G371-G379
19. Pond S.M., Davis C.K., Bogoyevitch M.A., Gordon R.A., Weisiger R.A., and Bass L. Uptake of palmitate by hepatocyte suspensions: facilitation by albumin?. Am. J. Physiol. 262 (1992) G883-G894
20. Mishina E.V., Straubinger R.M., Pyszczynski N.A., and Jusko W.J. Enhancement of tissue delivery and receptor occupancy of methylprednisolone in rats by a liposomal formulation. Pharm. Res. 10 (1993) 1402-1410
21. Senior J., and Gregoriadis G. Stability of small unilamellar liposomes in serum and clearance from the circulation: the effect of the phospholipid and cholesterol components. Life Sci. 30 (1982) 2123-2136
22. Frézard F., Santaella C., Vierling P., and Riess J.G. Permeability and stability in buffer and in human serum of fluorinated phospholipid-based liposomes. Biochim. Biophys. Acta 1192 (1994) 61-70
23. Takino T., Nakajima C., Takakura Y., Sezaki H., and Hashida M. Controlled biodistribution of highly lipophilic drugs with various parenteral formulations. J. Drug Target. 1 (1993) 117-124
24. Moghimi S.M., and Patel H.M. Serum opsonins and phagocytosis of saturated and unsaturated phospholipid liposomes. Biochim. Biophys. Acta 984 (1989) 384-387
25. Shibuya-Fujiwara N., Hirayama F., Ogata Y., Ikeda H., and Ikebuchi K. Phagocytosis in vitro of polyethylene glycol-modified liposome-encapsulated hemoglobin by human peripheral blood monocytes plus macrophages through scavenger receptors. Life Sci. 70 (2001) 291-300
26. Senior J., Delgado C., Fisher D., Tilcock C., and Gregoriadis G. Influence of surface hydrophilicity of liposomes on their interaction with plasma protein and clearance from the circulation: studies with poly(ethylene glycol)-coated vesicles. Biochim. Biophys. Acta 1062 (1991) 77-82
27. Bischoff K.B., Dedrick R.L., Zaharko D.S., and Longstreth J.A. Methotrexate pharmacokinetics. J. Pharm. Sci. 60 (1971) 1128-1133
28. 2. Physicochemical and biological properties of newly synthesized lipophilic derivatives of mitomycin C. Chem. Pharm. Bull. 36 (1988) 3060-3069